Keeps Biopharma Inc.
Develops cancer therapies and obesity drugs; manufactures industrial and cleanroom products.
256940 | KO
Overview
Corporate Details
- ISIN(s):
- KR7256940008
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 동탄면 동탄산단10길 52, 화성시
- Website:
- http://kpscorp.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Keeps Biopharma Inc. is a company with diversified operations in biopharmaceuticals and industrial manufacturing. The biopharmaceutical division focuses on the research and development of biomarker-driven targeted therapies for women's cancers, including ovarian, endometrial, and triple-negative breast cancer. The company is also advancing an oral obesity drug, which is reportedly undergoing primate trials. Operating under its former name, KPS Corp, the company's industrial segment manufactures and sells mechanical equipment for the flat panel display industry and produces cleanroom consumables such as wipers and adhesive rolls.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-02 00:00 |
M&A Activity
주요사항보고서(유형자산양수결정)
|
Korean | 15.9 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.8 MB | ||
| 2025-07-23 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 89.1 KB | ||
| 2025-07-10 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 89.0 KB | ||
| 2025-06-17 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 97.4 KB | ||
| 2025-06-17 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 6.2 KB | ||
| 2025-06-16 00:00 |
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
|
Korean | 91.6 KB | ||
| 2025-05-30 00:00 |
Share Issue/Capital Change
전환청구권행사
|
Korean | 14.1 KB | ||
| 2025-05-15 00:00 |
Annual Report
분기보고서 (2025.03)
|
Korean | 1.7 MB | ||
| 2025-04-10 00:00 |
M&A Activity
합병등종료보고서(합병)
|
Korean | 16.9 KB | ||
| 2025-04-09 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.2 KB | ||
| 2025-04-09 00:00 |
M&A Activity
주요사항보고서(타법인주식및출자증권양도결정)
|
Korean | 21.7 KB | ||
| 2025-03-31 00:00 |
Capital/Financing Update
기타경영사항(자율공시) (제5회차 무기명식 무보증 사모 전환사채 재매각의 건)
|
Korean | 12.2 KB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 26.3 KB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
상호변경안내
|
Korean | 5.6 KB |
Automate Your Workflow. Get a real-time feed of all Keeps Biopharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Keeps Biopharma Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Keeps Biopharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
